CD34 and type 2 diabetes mellitus: Similarly, CD34+ cells from T2DM patients exhibited a reduction in its vasodilatory, proliferative, migratory and angiogenic function, that seemed to be associated with changes in its secretory profile and a worsening of the response to hypoxia [114].